Published in Proc Natl Acad Sci U S A on January 16, 2013
Animal models of Parkinson's disease: a gateway to therapeutics? Neurotherapeutics (2014) 0.93
An Lmx1b-miR135a2 regulatory circuit modulates Wnt1/Wnt signaling and determines the size of the midbrain dopaminergic progenitor pool. PLoS Genet (2013) 0.88
Activated astrocytes enhance the dopaminergic differentiation of stem cells and promote brain repair through bFGF. Nat Commun (2014) 0.86
WNT-5A: signaling and functions in health and disease. Cell Mol Life Sci (2015) 0.86
Differentiation of human epidermal neural crest stem cells (hEPI-NCSC) into virtually homogenous populations of dopaminergic neurons. Stem Cell Rev (2014) 0.84
Wnt signaling in neuropsychiatric disorders: ties with adult hippocampal neurogenesis and behavior. Neurosci Biobehav Rev (2014) 0.83
Directed midbrain and spinal cord neurogenesis from pluripotent stem cells to model development and disease in a dish. Front Neurosci (2014) 0.82
The Role of Genetically Modified Mesenchymal Stem Cells in Urinary Bladder Regeneration. PLoS One (2015) 0.79
p300/β-Catenin Interactions Regulate Adult Progenitor Cell Differentiation Downstream of WNT5a/Protein Kinase C (PKC). J Biol Chem (2016) 0.78
Neural Conversion and Patterning of Human Pluripotent Stem Cells: A Developmental Perspective. Stem Cells Int (2016) 0.76
Histamine impairs midbrain dopaminergic development in vivo by activating histamine type 1 receptors. Mol Brain (2014) 0.76
The antidepressant roles of Wnt2 and Wnt3 in stress-induced depression-like behaviors. Transl Psychiatry (2016) 0.76
ERKed by LRRK2: a cell biological perspective on hereditary and sporadic Parkinson's disease. Biochim Biophys Acta (2013) 0.76
Dopamine Receptor Antagonists Enhance Proliferation and Neurogenesis of Midbrain Lmx1a-expressing Progenitors. Sci Rep (2016) 0.75
WNT signaling in midbrain dopaminergic neuron development and cell replacement therapies for Parkinson's disease. Springerplus (2015) 0.75
Proceedings: cell therapies for Parkinson's disease from discovery to clinic. Stem Cells Transl Med (2014) 0.75
Making a mes: A transcription factor-microRNA pair governs the size of the midbrain and the dopaminergic progenitor pool. Neurogenesis (Austin) (2015) 0.75
Wnt5a is a crucial regulator of neurogenesis during cerebellum development. Sci Rep (2017) 0.75
Otx2 Requires Lmx1b to Control the Development of Mesodiencephalic Dopaminergic Neurons. PLoS One (2015) 0.75
A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway. Mol Neurodegener (2017) 0.75
Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature (2003) 12.54
The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell (1990) 10.99
Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature (2011) 7.90
Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol (2009) 6.66
Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell (2011) 6.56
A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. Development (1999) 5.85
Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice. Genes Dev (2008) 4.38
Wnt-1 modulates cell-cell adhesion in mammalian cells by stabilizing beta-catenin binding to the cell adhesion protein cadherin. J Cell Biol (1994) 4.30
wingless signal and Zeste-white 3 kinase trigger opposing changes in the intracellular distribution of Armadillo. Development (1994) 4.04
Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development. Nature (1990) 3.92
LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell (2011) 3.78
Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat Biotechnol (2003) 3.43
FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell (1998) 3.33
Identification of intrinsic determinants of midbrain dopamine neurons. Cell (2006) 3.31
GSK3 signalling in neural development. Nat Rev Neurosci (2010) 3.29
Progress toward the clinical application of patient-specific pluripotent stem cells. J Clin Invest (2010) 3.12
Wnt11 and Ret/Gdnf pathways cooperate in regulating ureteric branching during metanephric kidney development. Development (2003) 3.08
A Wnt survival guide: from flies to human disease. J Invest Dermatol (2009) 2.91
Emerging roles of Wnts in the adult nervous system. Nat Rev Neurosci (2009) 2.69
To build a synapse: signaling pathways in neuromuscular junction assembly. Development (2010) 2.65
The foxa2 gene controls the birth and spontaneous degeneration of dopamine neurons in old age. PLoS Biol (2007) 2.54
Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner. Development (2007) 2.40
Wnt signaling in neural circuit assembly. Annu Rev Neurosci (2008) 2.35
The midbrain-hindbrain phenotype of Wnt-1-/Wnt-1- mice results from stepwise deletion of engrailed-expressing cells by 9.5 days postcoitum. Cell (1992) 2.27
Wnt-mediated self-renewal of neural stem/progenitor cells. Proc Natl Acad Sci U S A (2008) 2.15
Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a. Proc Natl Acad Sci U S A (2003) 2.14
Induction of midbrain dopaminergic neurons by Sonic hedgehog. Neuron (1995) 2.08
Wnt antagonism of Shh facilitates midbrain floor plate neurogenesis. Nat Neurosci (2009) 2.03
Wnt-1 induces growth, cytosolic beta-catenin, and Tcf/Lef transcriptional activation in Rat-1 fibroblasts. Mol Cell Biol (1998) 1.98
Engrailed-1 as a target of the Wnt-1 signalling pathway in vertebrate midbrain development. Nature (1996) 1.91
A Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivo. Development (2006) 1.79
Expression patterns of the homeo box-containing genes En-1 and En-2 and the proto-oncogene int-1 diverge during mouse development. Genes Dev (1988) 1.75
A quest for the mechanism regulating global planar cell polarity of tissues. Trends Cell Biol (2009) 1.60
Otx2 regulates the extent, identity and fate of neuronal progenitor domains in the ventral midbrain. Development (2004) 1.59
Neurogenin 2 is required for the development of ventral midbrain dopaminergic neurons. Development (2006) 1.58
Wnt1-lmx1a forms a novel autoregulatory loop and controls midbrain dopaminergic differentiation synergistically with the SHH-FoxA2 pathway. Cell Stem Cell (2009) 1.51
Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease. Trends Pharmacol Sci (2009) 1.51
Wnt signaling in development and disease. Neurobiol Dis (2009) 1.51
Specification of dopaminergic and serotonergic neurons in the vertebrate CNS. Curr Opin Neurobiol (1999) 1.43
Noncanonical Wnt signaling in vertebrate development, stem cells, and diseases. Birth Defects Res C Embryo Today (2010) 1.34
Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice. J Clin Invest (2008) 1.29
Interactions of Wnt/beta-catenin signaling and sonic hedgehog regulate the neurogenesis of ventral midbrain dopamine neurons. J Neurosci (2010) 1.26
Purified Wnt-5a increases differentiation of midbrain dopaminergic cells and dishevelled phosphorylation. J Neurochem (2005) 1.24
GSK-3beta inhibition/beta-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons. J Cell Sci (2004) 1.24
Multiple roles of beta-catenin in controlling the neurogenic niche for midbrain dopamine neurons. Development (2009) 1.23
The extracellular domain of Lrp5/6 inhibits noncanonical Wnt signaling in vivo. Mol Biol Cell (2008) 1.23
Control of neuronal diversity by the floor plate: contact-mediated induction of midbrain dopaminergic neurons. Cell (1995) 1.17
Towards stem cell replacement therapies for Parkinson's disease. Biochem Biophys Res Commun (2010) 1.16
Wnt5a regulates ventral midbrain morphogenesis and the development of A9-A10 dopaminergic cells in vivo. PLoS One (2008) 1.14
Distinct but redundant expression of the Frizzled Wnt receptor genes at signaling centers of the developing mouse brain. Neuroscience (2007) 1.08
Ryks: new partners for Wnts in the developing and regenerating nervous system. Trends Neurosci (2009) 1.08
Wnt/beta-catenin signaling blockade promotes neuronal induction and dopaminergic differentiation in embryonic stem cells. Stem Cells (2009) 1.08
Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease. Brain (2008) 1.06
Parkin protects dopaminergic neurons from excessive Wnt/beta-catenin signaling. Biochem Biophys Res Commun (2009) 1.02
Lrp6 is required for convergent extension during Xenopus gastrulation. Development (2007) 1.00
Wnt signaling signaling at and above the receptor level. Curr Top Dev Biol (2011) 0.97
Dynamic temporal and cell type-specific expression of Wnt signaling components in the developing midbrain. Exp Cell Res (2006) 0.96
The role of Wnt signaling in neuroprotection. Drug News Perspect (2009) 0.95
Abnormal development of mouse embryoid bodies lacking p27Kip1 cell cycle regulator. Stem Cells (2005) 0.94
Wnt2 regulates progenitor proliferation in the developing ventral midbrain. J Biol Chem (2009) 0.87
A small synthetic cripto blocking Peptide improves neural induction, dopaminergic differentiation, and functional integration of mouse embryonic stem cells in a rat model of Parkinson's disease. Stem Cells (2010) 0.85
beta-Catenin regulates intercellular signalling networks and cell-type specific transcription in the developing mouse midbrain-rhombomere 1 region. PLoS One (2010) 0.81
Emerging roles of Wnts in the adult nervous system. Nat Rev Neurosci (2009) 2.69
Exome capture reveals ZNF423 and CEP164 mutations, linking renal ciliopathies to DNA damage response signaling. Cell (2012) 2.54
Molecular basis of tubulin transport within the cilium by IFT74 and IFT81. Science (2013) 2.25
Histone H2AX-dependent GABA(A) receptor regulation of stem cell proliferation. Nature (2008) 2.24
Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a. Proc Natl Acad Sci U S A (2003) 2.14
Liver X receptors and oxysterols promote ventral midbrain neurogenesis in vivo and in human embryonic stem cells. Cell Stem Cell (2009) 1.84
A Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivo. Development (2006) 1.79
Derivation of mouse embryonic stem cells. Nat Protoc (2006) 1.76
Wnt-5a induces Dishevelled phosphorylation and dopaminergic differentiation via a CK1-dependent mechanism. J Cell Sci (2007) 1.65
Neurogenin 2 is required for the development of ventral midbrain dopaminergic neurons. Development (2006) 1.58
Cholestenoic acids regulate motor neuron survival via liver X receptors. J Clin Invest (2014) 1.55
Hypomorphic mutation of the TALE gene Prep1 (pKnox1) causes a major reduction of Pbx and Meis proteins and a pleiotropic embryonic phenotype. Mol Cell Biol (2006) 1.46
Beta-arrestin is a necessary component of Wnt/beta-catenin signaling in vitro and in vivo. Proc Natl Acad Sci U S A (2007) 1.46
Requirement for thyroid hormone receptor beta in T3 regulation of cholesterol metabolism in mice. Mol Endocrinol (2002) 1.32
Communication via gap junctions underlies early functional and beneficial interactions between grafted neural stem cells and the host. Proc Natl Acad Sci U S A (2010) 1.31
Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice. J Clin Invest (2008) 1.29
Wnt-3a utilizes a novel low dose and rapid pathway that does not require casein kinase 1-mediated phosphorylation of Dvl to activate beta-catenin. Cell Signal (2006) 1.26
Interactions of Wnt/beta-catenin signaling and sonic hedgehog regulate the neurogenesis of ventral midbrain dopamine neurons. J Neurosci (2010) 1.26
Purified Wnt-5a increases differentiation of midbrain dopaminergic cells and dishevelled phosphorylation. J Neurochem (2005) 1.24
GSK-3beta inhibition/beta-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons. J Cell Sci (2004) 1.24
CXXC5 is a novel BMP4-regulated modulator of Wnt signaling in neural stem cells. J Biol Chem (2008) 1.23
Cerebrospinal fluid steroidomics: are bioactive bile acids present in brain? J Biol Chem (2009) 1.23
The extracellular domain of Lrp5/6 inhibits noncanonical Wnt signaling in vivo. Mol Biol Cell (2008) 1.23
An efficient method for the derivation of mouse embryonic stem cells. Stem Cells (2005) 1.20
Receptor tyrosine kinases activate canonical WNT/β-catenin signaling via MAP kinase/LRP6 pathway and direct β-catenin phosphorylation. PLoS One (2012) 1.18
Amer1/WTX couples Wnt-induced formation of PtdIns(4,5)P2 to LRP6 phosphorylation. EMBO J (2011) 1.18
Wnt5a regulates midbrain dopaminergic axon growth and guidance. PLoS One (2011) 1.18
Neural progenitor cells engineered to secrete GDNF show enhanced survival, neuronal differentiation and improve cognitive function following traumatic brain injury. Eur J Neurosci (2006) 1.14
Wnt5a regulates ventral midbrain morphogenesis and the development of A9-A10 dopaminergic cells in vivo. PLoS One (2008) 1.14
Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells. Genes Dev (2003) 1.13
The p75 neurotrophin receptor interacts with multiple MAGE proteins. J Biol Chem (2002) 1.13
Beta-arrestin and casein kinase 1/2 define distinct branches of non-canonical WNT signalling pathways. EMBO Rep (2008) 1.12
Cup is a nucleocytoplasmic shuttling protein that interacts with the eukaryotic translation initiation factor 4E to modulate Drosophila ovary development. Proc Natl Acad Sci U S A (2004) 1.11
Ventral midbrain glia express region-specific transcription factors and regulate dopaminergic neurogenesis through Wnt-5a secretion. Mol Cell Neurosci (2005) 1.09
Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis. Nat Chem Biol (2012) 1.09
Midbrain dopaminergic neurogenesis and behavioural recovery in a salamander lesion-induced regeneration model. Development (2007) 1.09
Wnt/beta-catenin signaling blockade promotes neuronal induction and dopaminergic differentiation in embryonic stem cells. Stem Cells (2009) 1.08
NTera2: a model system to study dopaminergic differentiation of human embryonic stem cells. Stem Cells Dev (2005) 1.08
Wnt-11 signalling controls ventricular myocardium development by patterning N-cadherin and beta-catenin expression. Cardiovasc Res (2010) 1.06
Identification of midbrain floor plate radial glia-like cells as dopaminergic progenitors. Glia (2008) 1.06
Molecular pathology of the fibroblast growth factor family. Hum Mutat (2009) 1.06
Functional integration of grafted neural stem cell-derived dopaminergic neurons monitored by optogenetics in an in vitro Parkinson model. PLoS One (2011) 1.06
Wnt4/5a signalling coordinates cell adhesion and entry into meiosis during presumptive ovarian follicle development. Hum Mol Genet (2010) 1.06
The homeodomain transcription factor Prep1 (pKnox1) is required for hematopoietic stem and progenitor cell activity. Dev Biol (2007) 1.05
FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells. Exp Cell Res (2004) 1.05
Sequential activation and inactivation of Dishevelled in the Wnt/beta-catenin pathway by casein kinases. J Biol Chem (2011) 1.04
Differential expression of Wnts after spinal cord contusion injury in adult rats. PLoS One (2011) 1.03
Gender differences and determinants of health related quality of life in coronary patients: a follow-up study. BMC Cardiovasc Disord (2011) 1.02
Parkin protects dopaminergic neurons from excessive Wnt/beta-catenin signaling. Biochem Biophys Res Commun (2009) 1.02
Analysis of STAT1 activation by six FGFR3 mutants associated with skeletal dysplasia undermines dominant role of STAT1 in FGFR3 signaling in cartilage. PLoS One (2008) 1.02
Vang-like protein 2 and Rac1 interact to regulate adherens junctions. J Cell Sci (2010) 1.02
Huwe1-mediated ubiquitylation of dishevelled defines a negative feedback loop in the Wnt signaling pathway. Sci Signal (2014) 1.01
Neural progenitors organize in small-world networks to promote cell proliferation. Proc Natl Acad Sci U S A (2013) 1.01
Inhibition of mitochondrial complex III blocks neuronal differentiation and maintains embryonic stem cell pluripotency. PLoS One (2013) 1.00
Negative regulation of Wnt signaling mediated by CK1-phosphorylated Dishevelled via Ror2. FASEB J (2010) 1.00
Disruption of EphA/ephrin-a signaling in the nigrostriatal system reduces dopaminergic innervation and dissociates behavioral responses to amphetamine and cocaine. Mol Cell Neurosci (2004) 0.99
Valproic acid induces differentiation and inhibition of proliferation in neural progenitor cells via the beta-catenin-Ras-ERK-p21Cip/WAF1 pathway. BMC Cell Biol (2008) 0.98
Function of Wnts in dopaminergic neuron development. Neurodegener Dis (2006) 0.97
Wnt5a is required for endothelial differentiation of embryonic stem cells and vascularization via pathways involving both Wnt/beta-catenin and protein kinase Calpha. Circ Res (2008) 0.97
Analysis of bioactive oxysterols in newborn mouse brain by LC/MS. J Lipid Res (2012) 0.97
FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescence. Bone (2010) 0.96
Targeted lipidomic analysis of oxysterols in the embryonic central nervous system. Mol Biosyst (2009) 0.96
Dynamic temporal and cell type-specific expression of Wnt signaling components in the developing midbrain. Exp Cell Res (2006) 0.96
Secreted Wnt antagonist Dickkopf-1 controls kidney papilla development coordinated by Wnt-7b signalling. Dev Biol (2011) 0.95
Ca2+ and cAMP signaling in human embryonic stem cell-derived dopamine neurons. Stem Cells Dev (2010) 0.94
Control of neural stem cell adhesion and density by an electronic polymer surface switch. Langmuir (2008) 0.94
The beta-chemokines CCL2 and CCL7 are two novel differentiation factors for midbrain dopaminergic precursors and neurons. Exp Cell Res (2008) 0.93
Wnts are expressed in the spinal cord of adult mice and are differentially induced after injury. J Neurotrauma (2014) 0.92
Wnt-11 signaling leads to down-regulation of the Wnt/beta-catenin, JNK/AP-1 and NF-kappaB pathways and promotes viability in the CHO-K1 cells. Exp Cell Res (2008) 0.92
SFRP1 and SFRP2 dose-dependently regulate midbrain dopamine neuron development in vivo and in embryonic stem cells. Stem Cells (2012) 0.90
Cripto as a target for improving embryonic stem cell-based therapy in Parkinson's disease. Stem Cells (2005) 0.90
Delayed dopaminergic neuron differentiation in Lrp6 mutant mice. Dev Dyn (2010) 0.90
The antimicrobial peptide rCRAMP is present in the central nervous system of the rat. J Neurochem (2005) 0.89
NF449 is a novel inhibitor of fibroblast growth factor receptor 3 (FGFR3) signaling active in chondrocytes and multiple myeloma cells. J Biol Chem (2010) 0.89
Structural and functional characterization of the Wnt inhibitor APC membrane recruitment 1 (Amer1). J Biol Chem (2011) 0.88
Wnt4 regulates thymic cellularity through the expansion of thymic epithelial cells and early thymic progenitors. Blood (2011) 0.88
Wnt2 regulates progenitor proliferation in the developing ventral midbrain. J Biol Chem (2009) 0.87
Alpha-chemokines regulate proliferation, neurogenesis, and dopaminergic differentiation of ventral midbrain precursors and neurospheres. Stem Cells (2008) 0.86
Heterotrimeric G protein-dependent WNT-5A signaling to ERK1/2 mediates distinct aspects of microglia proinflammatory transformation. J Neuroinflammation (2012) 0.86
A secreted BMP antagonist, Cer1, fine tunes the spatial organization of the ureteric bud tree during mouse kidney development. PLoS One (2011) 0.86
Crucial role of TrkB ligands in the survival and phenotypic differentiation of developing locus coeruleus noradrenergic neurons. Development (2003) 0.86
Inhibition of canonical Wnt signaling promotes gliogenesis in P0-NSCs. Biochem Biophys Res Commun (2009) 0.86